Skip to main content
OpenTrials

Clinical trial condition

Uveal Neoplasms

Explore clinical trials studying Uveal Neoplasms. Study availability and eligibility vary by location and protocol.

200 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Uveal Neoplasms trial results

Active, Not Recruiting

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

NCT06784648

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +27 more
Locations
  • Charité - Universitatsmedizin Berlin Berlin, Germany
  • University Hospital Essen Essen, Germany
  • University Hospital Heidelberg Heidelberg, Germany
  • University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg and Clinical Cooperation Unit Dermato-Oncology(G300) German Cancer Research Center(DKFZ) Mannheim, Germany
View Trial Details
Active, Not Recruiting

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

NCT05812027

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

A Prospective Natural History Study in Uveal Melanoma

NCT04588662

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma

NCT05315258

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust (Screening only) Cambridge, United Kingdom
  • The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • The Clatterbridge Cancer Centre Liverpool, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Active, Not Recruiting

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

NCT05022901

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details

Related conditions